Related Experiment Video

Updated: Jun 23, 2026

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

Targeting critical steps of cancer metastasis and recurrence using telomerase template antagonists

Z Gunnur Dikmen1, Taner Ozgurtas, Sergei M Gryaznov

  • 1Department of Biochemistry, University of Hacettepe, 06100 Sihhiye, Ankara, Turkey. gunnur@hacettepe.edu.tr

Biochimica Et Biophysica Acta
|May 8, 2009
PubMed

Insights

Telomerase inhibitors show promise in targeting cancer stem cells to reduce tumor relapse and metastasis. This approach aims to overcome major obstacles in cancer treatment by inhibiting cellular immortality.

Area of Science:

  • Oncology
  • Cancer Biology
  • Molecular Medicine

Background:

  • Metastasis, tumor relapse, and drug resistance are significant challenges in cancer therapy.
  • Cancer stem cells (CSCs) are implicated in sustaining tumor growth and metastasis.
  • Telomerase and telomere maintenance are crucial for CSC immortality and proliferation.

Purpose of the Study:

  • To review the role of telomerase in cancer and CSC immortalization.
  • To discuss the therapeutic potential of targeting telomerase in cancer treatment.
  • To explore opportunities for telomerase inhibitors in combating metastasis and recurrence.

Main Methods:

  • Literature review focusing on telomerase function in cancer.
  • Analysis of evidence linking telomerase to cancer stem cells.
  • Discussion of therapeutic strategies involving telomerase inhibition.

Main Results:

  • Telomerase activity is essential for the immortal phenotype of cancer and CSCs.
  • Telomerase inhibitors offer a strategy to target CSCs and reduce tumor relapse.
  • Targeting telomerase may also inhibit critical steps in cancer metastasis.

Conclusions:

  • Telomerase is a key target for overcoming cancer stem cell-mediated tumor growth and metastasis.
  • Telomerase inhibitors hold significant therapeutic potential for reducing cancer recurrence and improving treatment outcomes.
  • Further research into telomerase inhibition strategies is warranted for comprehensive cancer therapy.

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Discovery of Metastatic Regulators using a Rapid and Quantitative Intravital Chick Chorioallantoic Membrane Model07:03

Discovery of Metastatic Regulators using a Rapid and Quantitative Intravital Chick Chorioallantoic Membrane Model

Published on: February 3, 2021

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...